Logo image of AKE.PA

ARKEMA (AKE.PA) Stock Fundamental Analysis

EPA:AKE - Euronext Paris - Matif - FR0010313833 - Common Stock - Currency: EUR

61.95  -1 (-1.59%)

Fundamental Rating

5

Overall AKE gets a fundamental rating of 5 out of 10. We evaluated AKE against 67 industry peers in the Chemicals industry. Both the profitability and the financial health of AKE get a neutral evaluation. Nothing too spectacular is happening here. AKE has a correct valuation and a medium growth rate. AKE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AKE was profitable.
AKE had a positive operating cash flow in the past year.
AKE had positive earnings in each of the past 5 years.
AKE had a positive operating cash flow in each of the past 5 years.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.15%, AKE is in line with its industry, outperforming 58.21% of the companies in the same industry.
AKE's Return On Equity of 4.18% is in line compared to the rest of the industry. AKE outperforms 59.70% of its industry peers.
AKE has a Return On Invested Capital (3.98%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AKE is in line with the industry average of 6.51%.
Industry RankSector Rank
ROA 2.15%
ROE 4.18%
ROIC 3.98%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

AKE has a Profit Margin of 3.21%. This is comparable to the rest of the industry: AKE outperforms 56.72% of its industry peers.
In the last couple of years the Profit Margin of AKE has declined.
AKE has a better Operating Margin (7.35%) than 62.69% of its industry peers.
AKE's Operating Margin has declined in the last couple of years.
AKE's Gross Margin of 19.95% is on the low side compared to the rest of the industry. AKE is outperformed by 71.64% of its industry peers.
In the last couple of years the Gross Margin of AKE has remained more or less at the same level.
Industry RankSector Rank
OM 7.35%
PM (TTM) 3.21%
GM 19.95%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AKE is creating some value.
The number of shares outstanding for AKE has been increased compared to 1 year ago.
AKE has less shares outstanding than it did 5 years ago.
AKE has a worse debt/assets ratio than last year.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 1.92 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
AKE's Altman-Z score of 1.92 is in line compared to the rest of the industry. AKE outperforms 40.30% of its industry peers.
AKE has a debt to FCF ratio of 13.87. This is a negative value and a sign of low solvency as AKE would need 13.87 years to pay back of all of its debts.
AKE has a Debt to FCF ratio (13.87) which is in line with its industry peers.
A Debt/Equity ratio of 0.50 indicates that AKE is not too dependend on debt financing.
The Debt to Equity ratio of AKE (0.50) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 13.87
Altman-Z 1.92
ROIC/WACC0.82
WACC4.85%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.43 indicates that AKE has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.43, AKE is doing good in the industry, outperforming 76.12% of the companies in the same industry.
AKE has a Quick Ratio of 1.64. This is a normal value and indicates that AKE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.64, AKE is in the better half of the industry, outperforming 77.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 1.64
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

The earnings per share for AKE have decreased by -8.80% in the last year.
The Earnings Per Share has been growing slightly by 0.10% on average over the past years.
Looking at the last year, AKE shows a small growth in Revenue. The Revenue has grown by 2.71% in the last year.
AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-8.8%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-29.35%
Revenue 1Y (TTM)2.71%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%1.71%

3.2 Future

Based on estimates for the next years, AKE will show a small growth in Earnings Per Share. The EPS will grow by 2.75% on average per year.
AKE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.83% yearly.
EPS Next Y-2.71%
EPS Next 2Y5.68%
EPS Next 3Y6.35%
EPS Next 5Y2.75%
Revenue Next Year1.65%
Revenue Next 2Y2.89%
Revenue Next 3Y3.26%
Revenue Next 5Y2.83%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.08 indicates a reasonable valuation of AKE.
AKE's Price/Earnings ratio is rather cheap when compared to the industry. AKE is cheaper than 95.52% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. AKE is valued rather cheaply when compared to this.
AKE is valuated cheaply with a Price/Forward Earnings ratio of 6.76.
Based on the Price/Forward Earnings ratio, AKE is valued cheaply inside the industry as 95.52% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.90. AKE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.08
Fwd PE 6.76
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

92.54% of the companies in the same industry are more expensive than AKE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AKE is valued a bit cheaper than 76.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.01
EV/EBITDA 4.91
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)82.65
EPS Next 2Y5.68%
EPS Next 3Y6.35%

7

5. Dividend

5.1 Amount

AKE has a Yearly Dividend Yield of 5.71%, which is a nice return.
Compared to an average industry Dividend Yield of 3.05, AKE pays a better dividend. On top of this AKE pays more dividend than 91.04% of the companies listed in the same industry.
AKE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 5.71%

5.2 History

On average, the dividend of AKE grows each year by 6.86%, which is quite nice.
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

AKE pays out 84.74% of its income as dividend. This is not a sustainable payout ratio.
The dividend of AKE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP84.74%
EPS Next 2Y5.68%
EPS Next 3Y6.35%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (7/4/2025, 7:00:00 PM)

61.95

-1 (-1.59%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-31 2025-07-31
Inst Owners55.8%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap4.71B
Analysts77.27
Price Target90.65 (46.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.71%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP84.74%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.56%
Min EPS beat(2)-18.44%
Max EPS beat(2)-8.67%
EPS beat(4)1
Avg EPS beat(4)-5.1%
Min EPS beat(4)-18.44%
Max EPS beat(4)8.44%
EPS beat(8)4
Avg EPS beat(8)-1.99%
EPS beat(12)8
Avg EPS beat(12)4.56%
EPS beat(16)12
Avg EPS beat(16)13.56%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)-0.57%
Revenue beat(4)1
Avg Revenue beat(4)-0.2%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)3.26%
Revenue beat(8)2
Avg Revenue beat(8)-1.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.31%
Revenue beat(16)9
Avg Revenue beat(16)1.05%
PT rev (1m)-6.51%
PT rev (3m)-14.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.15%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.22%
Valuation
Industry RankSector Rank
PE 8.08
Fwd PE 6.76
P/S 0.49
P/FCF 17.01
P/OCF 4.45
P/B 0.64
P/tB 2.27
EV/EBITDA 4.91
EPS(TTM)7.67
EY12.38%
EPS(NY)9.17
Fwd EY14.8%
FCF(TTM)3.64
FCFY5.88%
OCF(TTM)13.91
OCFY22.45%
SpS126.01
BVpS96.87
TBVpS27.29
PEG (NY)N/A
PEG (5Y)82.65
Profitability
Industry RankSector Rank
ROA 2.15%
ROE 4.18%
ROCE 5.64%
ROIC 3.98%
ROICexc 4.37%
ROICexgc 8.2%
OM 7.35%
PM (TTM) 3.21%
GM 19.95%
FCFM 2.89%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexcg growth 3Y-19.33%
ROICexcg growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 13.87
Debt/EBITDA 2.41
Cap/Depr 95.48%
Cap/Sales 8.15%
Interest Coverage 20.11
Cash Conversion 69.51%
Profit Quality 89.94%
Current Ratio 2.43
Quick Ratio 1.64
Altman-Z 1.92
F-Score5
WACC4.85%
ROIC/WACC0.82
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.8%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-29.35%
EPS Next Y-2.71%
EPS Next 2Y5.68%
EPS Next 3Y6.35%
EPS Next 5Y2.75%
Revenue 1Y (TTM)2.71%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%1.71%
Revenue Next Year1.65%
Revenue Next 2Y2.89%
Revenue Next 3Y3.26%
Revenue Next 5Y2.83%
EBIT growth 1Y-5.63%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year69.34%
EBIT Next 3Y25.14%
EBIT Next 5Y15.99%
FCF growth 1Y-63.26%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-28.95%
OCF growth 3Y7%
OCF growth 5Y-2.92%